IGC Pharma, Inc. IGC
Set alert
0.19 USD -0.01 -7.13%
At close · Oct 30
0.19 0.00 +2.00%
After hours · Oct 30, 7:59 PM ET
0.1808 Day range 0.197
0.185 52-week range 0.40
- YTD
- -33.93%
- 1 year
- -53.75%
- Open
- 0.191
- Prev close
- 0.1992
- Mkt cap
- 19.13M
- Vol
- 523.10K
- Avg vol
- 747.28K
- EPS
- -0.07
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.1808
- High
- 0.197
- Forward P/E
- -3.74
- Beta
- 1.29
- Short ratio
- 2.29
- Inst. own
- 22.00%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 12, 2025
- 50-d avg
- 0.3768
- 200-d avg
- 0.421
- 1y target
- 3.75
5Y chart
Events in this range
- Nov 9, 2023Earnings: -0.05; estimate 0; surprise —%
- Feb 14, 2024Earnings: -0.09; estimate 0; surprise —%
- Jun 21, 2024Rating: Ascendiant Capital · Buy → Buy
- Jun 24, 2024Earnings: -0.04; estimate 0; surprise —%
- Jul 17, 2024Rating: Alliance Global Partners · — → Buy
- Jul 29, 2024Rating: Ascendiant Capital · Buy → Buy
- Aug 8, 2024Earnings: -0.03; estimate 0; surprise —%
- Sep 3, 2024Rating: Ascendiant Capital · Buy → Buy
- Nov 12, 2024Earnings: -0.02; estimate -0.03; surprise 33.33%
- Dec 5, 2024Rating: Ascendiant Capital · Buy → Buy
- Feb 12, 2025Earnings: —; estimate -0.03; surprise —%
Signals (87)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 26, 2026 | 6 days ago |
| MACD: Sell Signal | Oct 12, 2026 | 2 weeks ago |
| SMA: Bearish | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Sep 21, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| SMA: Bearish | Sep 7, 2026 | 1 month ago |
| SMA: Bullish | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Aug 10, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 10, 2026 | 2 months ago |
| MACD: Sell Signal | Jun 15, 2026 | 4 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| SMA: Bearish | May 4, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| SMA: Bullish | Apr 6, 2026 | 6 months ago |
| MACD: Buy Signal | Mar 30, 2026 | 7 months ago |
| SMA: Bearish | Mar 23, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 23, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 16, 2026 | 7 months ago |
| SMA: Bearish | Nov 17, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 3, 2025 | 12 months ago |
| SMA: Bearish | Oct 27, 2025 | 1 year ago |
| SMA: Bullish | Oct 20, 2025 | 1 year ago |
| SMA: Bearish | Oct 13, 2025 | 1 year ago |
| SMA: Bullish | Jul 7, 2025 | 1 year ago |
| SMA: Bullish | Jul 7, 2025 | 1 year ago |
| SMA: Bearish | Jun 30, 2025 | 1 year ago |
| SMA: Bullish | Jun 23, 2025 | 1 year ago |
| SMA: Bearish | Jun 9, 2025 | 1 year ago |
| SMA: Bearish | May 26, 2025 | 1 year ago |
| SMA: Bullish | May 19, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 28, 2025 | 1 year ago |
| SMA: Bullish | Apr 21, 2025 | 1 year ago |
| SMA: Bearish | Mar 24, 2025 | 1 year ago |
| SMA: Bullish | Mar 10, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 6, 2025 | 1 year ago |
| SMA: Bearish | Dec 23, 2024 | 1 year ago |
| SMA: Bearish | Dec 16, 2024 | 1 year ago |
| SMA: Bullish | Dec 9, 2024 | 1 year ago |
| SMA: Bullish | Dec 9, 2024 | 1 year ago |
| MACD: Buy Signal | Dec 9, 2024 | 1 year ago |
| SMA: Bearish | Nov 11, 2024 | 1 year ago |
| SMA: Bullish | Oct 14, 2024 | 2 years ago |
| SMA: Bearish | Aug 19, 2024 | 2 years ago |
| SMA: Bullish | Aug 12, 2024 | 2 years ago |
| SMA: Bearish | Aug 5, 2024 | 2 years ago |
| SMA: Bearish | Jun 24, 2024 | 2 years ago |
| MACD: Sell Signal | Jun 24, 2024 | 2 years ago |
| SMA: Bullish | Jun 17, 2024 | 2 years ago |
| MACD: Buy Signal | Jun 17, 2024 | 2 years ago |
| MACD: Sell Signal | Jun 10, 2024 | 2 years ago |
| RSI: Overbought | Apr 1, 2024 | 2 years ago |
| SMA: Bullish | Feb 26, 2024 | 2 years ago |
| SMA: Bullish | Feb 5, 2024 | 2 years ago |
| MACD: Buy Signal | Feb 5, 2024 | 2 years ago |
| SMA: Bearish | Dec 4, 2023 | 2 years ago |
| SMA: Bullish | Nov 27, 2023 | 2 years ago |
| MACD: Sell Signal | Oct 16, 2023 | 3 years ago |
| SMA: Bearish | Oct 2, 2023 | 3 years ago |
| SMA: Bearish | Oct 2, 2023 | 3 years ago |
| SMA: Bullish | Sep 4, 2023 | 3 years ago |
| SMA: Bullish | Sep 4, 2023 | 3 years ago |
| SMA: Bearish | Aug 14, 2023 | 3 years ago |
| SMA: Bearish | Aug 14, 2023 | 3 years ago |
| SMA: Bullish | Jul 31, 2023 | 3 years ago |
| SMA: Bearish | Jul 17, 2023 | 3 years ago |
| SMA: Bullish | Jul 3, 2023 | 3 years ago |
| SMA: Bullish | Jul 3, 2023 | 3 years ago |
| SMA: Bearish | May 8, 2023 | 3 years ago |
| SMA: Bullish | May 1, 2023 | 3 years ago |
| SMA: Bearish | Apr 24, 2023 | 3 years ago |
| SMA: Bullish | Apr 17, 2023 | 3 years ago |
| SMA: Bearish | Mar 6, 2023 | 3 years ago |
| SMA: Bullish | Jan 16, 2023 | 3 years ago |
| RSI: Oversold | Dec 19, 2022 | 3 years ago |
| SMA: Bearish | Dec 5, 2022 | 3 years ago |
| SMA: Bullish | Nov 28, 2022 | 3 years ago |
| SMA: Bearish | Sep 12, 2022 | 4 years ago |
| SMA: Bullish | Sep 5, 2022 | 4 years ago |
| SMA: Bearish | Aug 29, 2022 | 4 years ago |
| SMA: Bullish | Jul 4, 2022 | 4 years ago |
| MACD: Buy Signal | Jul 4, 2022 | 4 years ago |
| RSI: Oversold | May 2, 2022 | 4 years ago |
| SMA: Bearish | Mar 28, 2022 | 4 years ago |
| SMA: Bullish | Mar 21, 2022 | 4 years ago |
| SMA: Bearish | Mar 7, 2022 | 4 years ago |
| RSI: Oversold | Mar 7, 2022 | 4 years ago |
| SMA: Bullish | Feb 14, 2022 | 4 years ago |
Key statistics
- Market cap
- 28.94M
- Enterprise value
- 26.29M
- Trailing P/E
- 0.00
- Forward P/E
- -3.74
- PEG ratio
- 0.00
- Price / sales
- 27.25
- Price / book
- 3.40
- EPS (TTM)
- -0.20
- Beta
- 1.29
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 1.06M
- Revenue growth
- -51.00%
- Free cash flow
- -3.51M
- Total cash
- 1.82M
- Total debt
- 338.00K
- Return on equity
- -126.20%
- Shares outstanding
- 77.45M
- Short % of float
- 2.40%
- 50-day average
- 0.3768
- 200-day average
- 0.421
Analyst view
Consensus: none
Price target (mean) 3.75 +1927.0% upside
Now 0.185
- Target (low)
- 3.50
- Target (mean)
- 3.75
- Target (high)
- 4.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy0
- Buy2
- Hold0
- Sell0
- Strong sell0
Next earnings
Feb 12, 2025
Expected Feb 12, 2025. Consensus EPS estimate -0.03.
Financials — quick view
IGC Revenue — quarterly 265.00K
IGC Net income — quarterly -2.94M
IGC EPS — quarterly -0.03
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 12, 2025 | Dec 1, 2024 | -0.03 | — | — | — |
| Nov 12, 2024 | Sep 1, 2024 | -0.03 | -0.02 | +0.01 | +33.33% |
| Aug 8, 2024 | Jun 1, 2024 | 0.00 | -0.03 | — | — |
| Jun 24, 2024 | Mar 1, 2024 | 0.00 | -0.04 | — | — |
| Feb 14, 2024 | Dec 1, 2023 | 0.00 | -0.09 | — | — |
| Nov 9, 2023 | Sep 1, 2023 | 0.00 | -0.05 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 5, 2024 | Ascendiant Capital | main | Buy | Buy |
| Sep 3, 2024 | Ascendiant Capital | main | Buy | Buy |
| Jul 29, 2024 | Ascendiant Capital | main | Buy | Buy |
| Jul 17, 2024 | Alliance Global Partners | init | — | Buy |
| Jun 21, 2024 | Ascendiant Capital | reit | Buy | Buy |
About IGC Pharma, Inc.
IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease. The company's lead product is IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63, IGC-1C, IGC-M3, and LMP in pre-clinical development. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- igcpharma.com
News
- Why Celestica Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
- 12 Health Care Stocks Moving In Wednesday's After-Market Session
- IGC Pharma Unveils PRISM AI Platform to Move Alzheimer's Risk Prediction to Brain-Health Action and Commercial Deployment
- IGC Pharma, Inc. (NYSEAMERICAN:IGC) Stock Short Interest Jumps 48.0%
- 'DEA Judge Pauses Marijuana Rescheduling Hearing As Opponents Highlight Government Report Detailing ‘Gaps’ In Federal Processes'- Marijuana Moment
- IGC Pharma Completes Enrollment in Phase 2 CALMA Alzheimer's Trial; Topline Results Expected Q4 2026
- Ascendiant Capital Maintains Buy on IGC Pharma, Raises Price Target to $6
- IGC Pharma Q2 EPS $(0.03) Misses $(0.02) Estimate, Sales $265.000K Beat $258.000K Estimate
- IGC Pharma Reports Q2 2026 Results as CALMA Alzheimer's Trial Moves Within Six Randomizations of Enrollment Closure
- IGC Pharma Strengthens Regulatory Readiness as Phase 2 CALMA Alzheimer's Trial Approaches Enrollment Closure and Q4 Topline Readout
Your note
Sign in to keep a note on IGC — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BRADBURY STRATEGIC INVESTMENT FUND A | Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Mar 21, 2024 | 13,823,500 |
| GRIMALDI CLAUDIA | Director | Conversion of Exercise of derivative security | Mar 12, 2024 | 1,037,150 |
| MORAN JAMES P | Director | Purchase | Sep 24, 2024 | 0 |
| MUKUNDA RAM | Chief Executive Officer | Stock Gift | Mar 12, 2024 | 4,336,760 |
| PRINS RICHARD K | Director | Stock Gift | Aug 11, 2024 | 1,042,920 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 1.78% | 703,798 | 263.01K | Sep 29, 2024 |
| Vanguard Group Inc | 1.63% | 645,166 | 241.10K | Sep 29, 2024 |
| Geode Capital Management, LLC | 1.42% | 562,969 | 210.38K | Sep 29, 2024 |
| State Street Corporation | 0.42% | 165,307 | 61.77K | Sep 29, 2024 |
| Virtu Financial LLC | 0.31% | 123,060 | 45.99K | Sep 29, 2024 |
| Dearborn Partners, L.L.C. | 0.29% | 116,401 | 43.50K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 1.59% | 630,222 | 235.51K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.98% | 387,255 | 144.72K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.25% | 99,144 | 37.05K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.23% | 91,469 | 34.18K | Oct 30, 2024 |